| | Webinar: How Providence is Tapping into the Benefits of Patient Activation Tuesday, November 10 | 1pm ET / 10am PT Our healthcare industry has only begun to tap the benefits of patient activation to avoid disruption & improve clinical outcomes, operational efficiency & financial performance. In this session, a panel of experts will review Providence’s My COVID Diary & My Surgical Journey projects & their ability to deliver patient-centric care, & measurable quality, revenue & patient satisfaction improvements. Register Now! |
Trial chief tips AstraZeneca COVID-19 vaccine for 2020 data drop Healthcare is ramping up AI investments during COVID. But the industry is still on the fence about Google, Amazon. Here's why Pfizer goes solo on US shot distribution, opting out of government channels Singapore startup develops 60-second COVID-19 breathalyzer test Fosun follows BioNTech in changing COVID-19 vaccine, plans bridging study for Chinese filing HHS wants to review most of its existing regulations and sunset burdensome, obsolete rules Healthcare roundup: Economy tops pandemic as key concern for voters, exit polls show Biopharma roundup: AstraZeneca falls short of UK shot production timeline, official says; Russia's vaccination plan hits manufacturing snags: report BD nets Dutch government contract for over 9M rapid antigen tests for COVID-19 Featured Story | By Nick Paul Taylor AstraZeneca has a good chance of delivering late-phase data on its COVID-19 vaccine this year, the chief investigator of the Oxford Vaccine Trial said. The timing gives AstraZeneca a “small chance” of being able to start distributing the AZD1222 vaccine in the U.K. before Christmas. read more |
| |
|---|
|
Top Stories By Heather Landi Healthcare organizations are ramping up their investments in artificial intelligence in response to the COVID-19 pandemic, according to survey data. But they are not turning to tech giants like Google and Amazon to deploy these technologies. Here's why. read more By Arlene Weintraub If Pfizer's COVID-19 mRNA vaccine is approved, it will not use the government’s chosen distribution provider, McKesson Corp., but rather its own just-in-time system to deliver it, a top executive said. The need to keep the vaccine at an ultra-cold temperature is one reason for that choice. read more By Conor Hale Singapore’s Breathonix has said a clinical trial of its COVID-19 breathalyzer test was able to achieve at least 90% accuracy after screening participants on-site for 60 seconds. read more By Nick Paul Taylor Fosun Pharma has stopped development of BioNTech’s first COVID-19 vaccine, following the lead of its German partner by picking BNT162b2 as the candidate to take to market. read more By Robert King HHS introduced a proposed rule intended to determine whether existing regulations are creating a burden or obsolete, with the review potentially affecting nearly 2,500 existing rules. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner AstraZeneca missed its target to supply 30 million U.K. shot doses by September, a British official said. Russia's vaccination plan reportedly hit manufacturing and quality control hurdles. Singapore's Breathonix is testing a COVID-19 breathalyzer. The FDA warned about possible false positives from antigen tests. read more By Conor Hale BD has secured a purchase order from the Netherlands to provide millions of rapid COVID-19 antigen tests to the country, marking its first government contract in Europe since the diagnostic received a CE mark in September. read more |
